Literature DB >> 7614987

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

E Pinelli1, R M Gonzalo, C J Boog, V P Rutten, D Gebhard, G del Real, E J Ruitenberg.   

Abstract

Protective immunity to leishmaniasis has been demonstrated in murine models to be mediated by T cells and the cytokines they produce. We have previously shown that resistance to experimental Leishmania infantum infection in the dog, a natural host and reservoir of the parasite, is associated with the proliferation of peripheral blood mononuclear cells (PBMC) to parasite antigen and to the production of interleukin-2 and tumour necrosis factor. In this study we show that PBMC from asymptomatic experimentally infected dogs produce interferon-gamma upon parasite antigen-specific stimulation, whereas lymphocytes from symptomatic dogs do not. In addition, we report for the first time the lysis of L. infantum-infected macrophages by PBMC from asymptomatic dogs and by parasite-specific T cell lines derived from these animals. These T cell lines were generated by restimulation in vitro with parasite soluble antigen and irradiated autologous PBMC as antigen-presenting cells. We show that lysis of infected macrophages by T cell lines is major histocompatibility complex restricted. Characterization of parasite-specific cytotoxic T cell lines revealed that the responding cells are CD8+. However, for some animals, CD4+ T cells that lyse infected macrophages were also found. In contrast to asymptomatic dogs, lymphocytes from symptomatic dogs failed to proliferate and produce interferon-gamma after Leishmania antigen stimulation in vitro and were not capable of lysing infected macrophages. These results suggest that both the production of interferon-gamma and the destruction of the parasitized host cells by Leishmania-specific T cells play an important role in resistance to visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614987     DOI: 10.1002/eji.1830250619

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

Authors:  E Pinelli; V P Rutten; M Bruysters; P F Moore; E J Ruitenberg
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

Authors:  L Solano-Gallego; P Morell; M Arboix; J Alberola; L Ferrer
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS.

Authors:  Claudio Nazaretian Rossi; Thaise Yumie Tomokane; Luis Fábio da Silva Batista; Mary Marcondes; Carlos Eduardo Larsson; Márcia Dalastra Laurenti
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-07-11       Impact factor: 1.846

4.  Asymptomatic canine leishmaniasis in Greater Athens area, Greece.

Authors:  V Sideris; G Papadopoulou; E Dotsika; E Karagouni
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

5.  Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells.

Authors:  C Mary; V Auriault; B Faugère; A J Dessein
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs.

Authors:  A DE F Michelin; S H V Perri; V M F De Lima
Journal:  Ann Trop Med Parasitol       Date:  2011-07

Review 7.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

8.  Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Authors:  Joelma Trigo; Melissa Abbehusen; Eduardo M Netto; Maria Nakatani; Geraldo Pedral-Sampaio; Robson Silva de Jesus; Yasuyuki Goto; Jeffrey Guderian; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

9.  Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi.

Authors:  A B Reis; A Teixeira-Carvalho; R C Giunchetti; L L Guerra; M G Carvalho; W Mayrink; O Genaro; R Corrêa-Oliveira; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

10.  Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis.

Authors:  L L Guerra; A Teixeira-Carvalho; R C Giunchetti; O A Martins-Filho; A B Reis; R Corrêa-Oliveira
Journal:  Parasitol Res       Date:  2008-11-05       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.